C4 Therapeutics (CCCC) PT Raised to $13 at Stifel
Tweet
Share
E-mailGet Alerts CCCC Hot Sheet
Price: $4.24 +3.92%
Rating Summary:
10 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
10 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Stifel analyst Bradley Canino raised the price target on C4 Therapeutics (NASDAQ: CCCC) to $13.00 (from $12.00) while maintaining a Buy rating.
You May Also Be Interested In
- C4 Therapeutics, Inc. (CCCC) Tops Q2 EPS by 3c
- Petronet LNG Ltd. (PLNG:IN) PT Raised to INR310 at ICICI Securities
- Stantec Inc. (STN:CN) (STN) PT Lowered to Cdn$169 at Desjardins
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
